Endoscopic & Oncoplastic Breast Surgery Center, Changhua Christian Hospital, Changhua, Taiwan; Division of General Surgery, Changhua Christian Hospital, Changhua, Taiwan; Comprehensive Breast Cancer Center, Changhua Christian Hospital, Changhua, Taiwan; Minimal Invasive Surgery Research Center, Changhua Christian Hospital, Changhua, Taiwan; Division of Breast Surgery, Yuanlin Christian Hospital, Yuanlin, Taiwan; Kaohsiung Medical University, Kaohsiung, Taiwan; School of Medicine, Chung Shan Medical University, Taichung, Taiwan; Chang Gung University College of Medicine, Taoyuan City, Taiwan; Division of General Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Division of Breast Surgery, Department of Surgery, Changi General Hospital, Singapore; Singhealth Duke-NUS Breast Centre, Singapore.
Eur J Surg Oncol. 2020 Aug;46(8):1446-1455. doi: 10.1016/j.ejso.2020.02.020. Epub 2020 Feb 20.
Endoscopic assisted breast surgery was associated with small and inconspicuous scar and endoscopic assisted breast conserving surgery (E-BCS) for breast cancer was increasingly performed as well. The clinical outcomes, learning curve analysis and patient reported cosmetic result of E-BCS for breast cancer were reported along with a review of the current literature.
A retrospective study analyzing the outcomes of E-BCS for breast cancer patients through an endoscopic breast surgery database in a single institution from June 2009 to May 2019 was performed and a literature review through Pubmed and Medline was conducted as well.
100 consecutive breast cancer patients who underwent E-BCS were analyzed. The mean age of patients was 52.5 years old. Furthermore, the mean pathologic tumor size was 1.6 cm and majority of patients had early stage (13% stage 0, 56% stage I, and 30% stage II) breast cancer. The mean operation time of E-BCS in the current study was 133 ± 50 min and in learning curve analysis, after accumulation of 15 consecutive cases the operation time significantly decreased. The morbidities of E-BCS were minor and most of them were skin flap related. The margin involvement rate was 4%. About 98% of patients surveyed were satisfied with the incision length, location and scar appearance of E-BCS whereas all of them were satisfied with E-BCS in general. With a mean follow-up of 29.2 ± 24.4 months, 3% of patients developed locoregional recurrences, 3% had distant metastasis and there were 2 mortalities observed.
In our preliminary experience, E-BCS is a promising surgical technique for selected early breast cancer patients with low morbidity, acceptable oncological outcomes and high patient satisfaction.
内镜辅助乳房手术具有切口小且隐蔽的特点,因此内镜辅助保乳手术(E-BCS)也越来越多地用于治疗乳腺癌。本文报道了 E-BCS 治疗乳腺癌的临床结果、学习曲线分析和患者报告的美容效果,并对当前文献进行了回顾。
对单中心内镜乳房手术数据库中 2009 年 6 月至 2019 年 5 月期间接受 E-BCS 治疗的乳腺癌患者的资料进行回顾性分析,并通过 Pubmed 和 Medline 进行文献复习。
共分析了 100 例连续接受 E-BCS 治疗的乳腺癌患者,患者平均年龄为 52.5 岁,肿瘤平均最大径为 1.6cm,多数患者为早期(0 期 13%,Ⅰ期 56%,Ⅱ期 30%)乳腺癌。E-BCS 的平均手术时间为 133±50min,在学习曲线分析中,连续 15 例手术完成后,手术时间显著缩短。E-BCS 的并发症轻微,多数与皮瓣相关,切缘阳性率为 4%。接受调查的患者中,98%对 E-BCS 的切口长度、位置和瘢痕外观满意,所有患者对 E-BCS 总体满意度高。平均随访 29.2±24.4 个月,3%的患者发生局部区域复发,3%发生远处转移,2 例死亡。
在我们的初步经验中,E-BCS 是一种有前途的治疗选择,用于治疗早期乳腺癌患者,具有较低的发病率、可接受的肿瘤学结果和较高的患者满意度。